Should we routinely treat patients with autoimmune/rheumatic diseases and chronic hepatitis B virus infection starting biologic therapies with antiviral agents? Yes

✍ Scribed by Dimitrios Vassilopoulos

• Book ID: 116432652
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 163 KB
• Volume: 22
• Category: Article
• ISSN: 0953-6205
• DOI: 10.1016/j.ejim.2011.09.001